HUP1000033D0 - Novel compounds with medicinal effect - Google Patents
Novel compounds with medicinal effectInfo
- Publication number
- HUP1000033D0 HUP1000033D0 HU1000033A HUP1000033A HUP1000033D0 HU P1000033 D0 HUP1000033 D0 HU P1000033D0 HU 1000033 A HU1000033 A HU 1000033A HU P1000033 A HUP1000033 A HU P1000033A HU P1000033 D0 HUP1000033 D0 HU P1000033D0
- Authority
- HU
- Hungary
- Prior art keywords
- novel compounds
- medicinal effect
- medicinal
- effect
- novel
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 230000007721 medicinal effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU1000033A HUP1000033A2 (en) | 2010-01-21 | 2010-01-21 | Piperazine derivatives useful against mycobacteriums |
| PCT/HU2011/000008 WO2011089456A1 (en) | 2010-01-21 | 2011-01-21 | Novel medicinal compounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU1000033A HUP1000033A2 (en) | 2010-01-21 | 2010-01-21 | Piperazine derivatives useful against mycobacteriums |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP1000033D0 true HUP1000033D0 (en) | 2010-03-29 |
| HUP1000033A2 HUP1000033A2 (en) | 2011-07-28 |
Family
ID=44306425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU1000033A HUP1000033A2 (en) | 2010-01-21 | 2010-01-21 | Piperazine derivatives useful against mycobacteriums |
Country Status (2)
| Country | Link |
|---|---|
| HU (1) | HUP1000033A2 (en) |
| WO (1) | WO2011089456A1 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1668584A (en) * | 2002-09-20 | 2005-09-14 | 鲁宾有限公司 | Pyrrole derivatives as antimycobacterial compounds |
| US7491721B2 (en) * | 2004-05-12 | 2009-02-17 | Lupin Limited | Antimycobacterial pharmaceutical composition |
-
2010
- 2010-01-21 HU HU1000033A patent/HUP1000033A2/en unknown
-
2011
- 2011-01-21 WO PCT/HU2011/000008 patent/WO2011089456A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| HUP1000033A2 (en) | 2011-07-28 |
| WO2011089456A1 (en) | 2011-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1246170A1 (en) | Pharmaceutical composition | |
| ZA201304158B (en) | Dosage form | |
| EP2543405A4 (en) | Syringe | |
| GB201010193D0 (en) | Medicinal use | |
| IL225457A0 (en) | Pharmaceutical composition | |
| LT2619182T (en) | Pharmaceutical composition | |
| GB201008005D0 (en) | Pharmaceutical compounds | |
| SG10201507079WA (en) | Syringe | |
| PT2579858E (en) | Ivabradine-containing pharmaceutical composition | |
| GB201010453D0 (en) | Pharmaceutical composition | |
| EP2769718A4 (en) | Medicinal composition | |
| GB201020161D0 (en) | Pharmaceutical compounds | |
| EP2654872A4 (en) | Self-dilating cannula | |
| EP2564852A4 (en) | Anti-brain-tumor drug | |
| PT2536400E (en) | Medicament comprising myramistin | |
| GB201001911D0 (en) | Pharmaceutical composition | |
| HUP1000033D0 (en) | Novel compounds with medicinal effect | |
| IL223324A0 (en) | Novel pharmaceutical compounds | |
| GB201001317D0 (en) | Medicament | |
| GB201021361D0 (en) | Pharmaceutical Compounds | |
| GB201020365D0 (en) | Pharmaceutical compounds | |
| GB201020364D0 (en) | Pharmaceutical compounds | |
| GB201020366D0 (en) | Pharmaceutical compounds | |
| GB201020068D0 (en) | Pharmaceutical compounds | |
| GB201013968D0 (en) | Pharmaceutical compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |